Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Laboratoire Hospitalier Universitaire de Bruxelles, Universitair Laboratorium Brussel (LHUB-ULB), Brussels, Belgium.
Acta Clin Belg. 2022 Apr;77(2):329-336. doi: 10.1080/17843286.2020.1868906. Epub 2021 Jan 6.
There is a trend towards decentralisation of laboratory tests by means of Point-of-Care testing (POCT). Within hospitals, Belgian law requires a POCT policy, coordinated by the clinical laboratory. There is however no legal framework for POCT performed outside the hospital: no reimbursement, no compulsory quality monitoring and no limits nor control on the prices charged to the patient. Uncontrolled use of POCT can have negative consequences for individual and public health.
We propose that POCT outside hospitals would only be reimbursed for tests carried out within a legal framework, requiring evidence-based testing and collaboration with a clinical laboratory, because clinical laboratories have procedures for test validation and quality monitoring, are equipped for electronic data transfer, are familiar with logistical processes, can provide support when technical issues arise and can organise and certify training. Under these conditions the government investment will be offset by health benefits, e.g. fall in antibiotic consumption with POCT for CRP in primary care, quick response to SARS-CoV2-positive cases in COVID-19 triage centres.
1° extension of the Belgian decree on certification of clinical laboratories to decentralised tests in primary care; 2° introduction of a separate reimbursement category for POCT; 3° introduction of reimbursement for a limited number of specified POCT; 4° setup of a Multidisciplinary POCT Advisory Council, the purpose of which is to draw up a model for reimbursement of POCT, to select tests eligible for reimbursement and to make proposals to the National Institute for Health and Disability Insurance ().
通过即时检验(POCT),实验室检测正呈现出去中心化的趋势。在医院内部,比利时法律要求临床实验室制定 POCT 政策,对其进行协调管理。然而,对于医院外的 POCT 并无法律框架:既无报销,亦无强制性质量监测,也没有对患者收取的费用进行限制或控制。POCT 的不受控制的使用可能会对个人和公共健康产生负面影响。
我们建议,只有在符合法律框架的情况下,对医院外的 POCT 检测进行报销,该框架要求基于证据的检测并与临床实验室合作,因为临床实验室具有测试验证和质量监测程序,配备了电子数据传输设备,熟悉物流流程,在出现技术问题时可以提供支持,并可以组织和认证培训。在这些条件下,政府的投资将通过健康效益得到弥补,例如,在初级保健中使用 CRP 的 POCT 检测减少抗生素的使用,在 COVID-19 分诊中心快速响应 SARS-CoV2 阳性病例。
1° 将比利时关于临床实验室认证的法令扩展到初级保健中的分散测试;2° 为 POCT 引入单独的报销类别;3° 为有限数量的特定 POCT 引入报销;4° 建立一个多学科 POCT 咨询委员会,其目的是制定 POCT 报销模型,选择有资格报销的检测,并向国家健康和残疾保险研究所()提出建议。